Investing

VEON, Vascular Biogenics Sink into Thursday's 52-Week Low Club

March 8, 2018: Here are four stocks trading with heavy volume among 50 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by roughly 8 to 7 and on the Nasdaq, advancers led decliners by about the same ratio.

VEON Ltd. (NASDAQ: VEON) fell about 3.7% Thursday to post a new 52-week low of $2.61 after closing at $2.71 on Wednesday. The 52-week high is $4.47. Volume of nearly 12.5 million was about three times the daily average. The stock turned the corner mid-morning is on track to close up about 1.1%.

Vascular Biogenics Ltd. (NASDAQ: VLBT)) dropped about 66% Thursday to post a new 52-week low of $2.30. Shares closed at $6.80 on Wednesday and the stock’s 52-week high is $9.05. Volume was about 35 times the daily average of around 220,000. The company’s cancer treatment failed to meet its primary endpoint in a phase 3 trial.

PPL Corp. (NYSE: PPL) traded down about 0.3% Thursday and posted a new 52-week low of $27.13 after closing Wednesday at $27.21. The stock’s 52-week high is $40.20. Volume was about 10% lower than the daily average of around 7 million shares. The company had no specific news and shares have charted a course to finish up nearly 2% for the day.

Outfront Media Inc. (NYSE: OUT) traded down about 1.9% Thursday and posted a new 52-week low of $18.98 after closing Wednesday at $19.35. The stock’s 52-week high is $26.97. Volume was around 3.4 million, nearly four times the daily average of around less than 1 million. The company had no specific news.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.